Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

RSV 2007: recent advances in respiratory syncytial virus research.

Stevens WW, Falsey AR, Braciale TJ.

Viral Immunol. 2008 Jun;21(2):133-40. doi: 10.1089/vim.2008.0012.

2.

RSV 2010: Recent advances in research on respiratory syncytial virus and other pneumoviruses.

van Bleek GM, Osterhaus AD, de Swart RL.

Vaccine. 2011 Oct 6;29(43):7285-91. doi: 10.1016/j.vaccine.2011.07.114. Epub 2011 Aug 7.

PMID:
21827813
3.

Hot topics in the prevention of respiratory syncytial virus disease.

Habibi MS, Patel S, Openshaw P.

Expert Rev Vaccines. 2011 Mar;10(3):291-3. doi: 10.1586/erv.11.13.

PMID:
21434796
4.

Preventive and therapeutic strategies for respiratory syncytial virus infection.

Vujovic O, Mills J.

Curr Opin Pharmacol. 2001 Oct;1(5):497-503. Review.

PMID:
11764776
5.

Mucosal vaccines against respiratory syncytial virus.

Yang K, Varga SM.

Curr Opin Virol. 2014 Jun;6:78-84. doi: 10.1016/j.coviro.2014.03.009. Epub 2014 Apr 29. Review.

6.

Identifying targets in the hunt for effective respiratory syncytial virus interventions.

Tayyari F, Hegele RG.

Expert Rev Respir Med. 2012 Apr;6(2):215-22. doi: 10.1586/ers.12.8. Review.

PMID:
22455493
7.

Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

Olson MR, Varga SM.

Expert Rev Vaccines. 2008 Oct;7(8):1239-55. doi: 10.1586/14760584.7.8.1239. Review.

8.

New strategies for control of respiratory syncytial virus infection.

Nokes JD, Cane PA.

Curr Opin Infect Dis. 2008 Dec;21(6):639-43. doi: 10.1097/QCO.0b013e3283184245. Review.

PMID:
18978532
9.

Respiratory syncytial virus: current progress in vaccine development.

Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL.

Viruses. 2013 Feb 5;5(2):577-94. doi: 10.3390/v5020577. Review.

10.

RSV 2005: Global impact, changing concepts, and new challenges.

Openshaw PJ, Tregoning J, Harker J.

Viral Immunol. 2005;18(4):749-51. No abstract available.

PMID:
16359242
11.

Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.

González PA, Bueno SM, Riedel CA, Kalergis AM.

Curr Med Chem. 2009;16(34):4609-25. Review.

PMID:
19903147
12.

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.

Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A.

J Virol. 2014 Apr;88(8):4237-50. doi: 10.1128/JVI.03481-13. Epub 2014 Jan 29.

13.

A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease.

Lindell DM, Morris SB, White MP, Kallal LE, Lundy PK, Hamouda T, Baker JR Jr, Lukacs NW.

PLoS One. 2011;6(7):e21823. doi: 10.1371/journal.pone.0021823. Epub 2011 Jul 15.

14.

The use of a neonatal mouse model to study respiratory syncytial virus infections.

Cormier SA, You D, Honnegowda S.

Expert Rev Anti Infect Ther. 2010 Dec;8(12):1371-80. doi: 10.1586/eri.10.125. Review.

15.

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Martinez-Sobrido L, Gitiban N, Fernandez-Sesma A, Cros J, Mertz SE, Jewell NA, Hammond S, Flano E, Durbin RK, García-Sastre A, Durbin JE.

J Virol. 2006 Feb;80(3):1130-9.

16.

New insights for development of a safe and protective RSV vaccine.

Blanco JC, Boukhvalova MS, Shirey KA, Prince GA, Vogel SN.

Hum Vaccin. 2010 Jun;6(6):482-92. Epub 2010 Jun 1. Review.

17.

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.

Graham BS.

Immunol Rev. 2011 Jan;239(1):149-66. doi: 10.1111/j.1600-065X.2010.00972.x. Review.

19.

Challenges and opportunities for respiratory syncytial virus vaccines.

Graham BS, Anderson LJ.

Curr Top Microbiol Immunol. 2013;372:391-404. doi: 10.1007/978-3-642-38919-1_20.

PMID:
24362701
20.

Host response to respiratory syncytial virus infection.

Arruvito L, Raiden S, Geffner J.

Curr Opin Infect Dis. 2015 Jun;28(3):259-66. doi: 10.1097/QCO.0000000000000159. Review.

PMID:
25887611
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk